Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001) is a clinical research site located in New Haven, Connecticut, United States 06510.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001) has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.